RhumbLine Advisers
SKIN icon

RhumbLine Advisers’s SkinHealth Systems SKIN Stock Holding History

RhumbLine Advisers’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Sell
25,079
-102,048
-80% -$78K ﹤0.01% 3835
2026
Q1 		$113K Sell
127,127
-3,888
-3% -$4.77K ﹤0.01% 3360
2025
Q4 		$182K Sell
131,015
-19,109
-13% -$27.6K ﹤0.01% 3218
2025
Q3 		$299K Buy
150,124
+8,142
+6% +$16.5K ﹤0.01% 2999
2025
Q2 		$271K Buy
141,982
+31,565
+29% +$44.5K ﹤0.01% 3055
2025
Q1 		$148K Buy
110,417
+2,981
+3% +$4.54K ﹤0.01% 3257
2024
Q4 		$171K Buy
107,436
+3,355
+3% +$5.27K ﹤0.01% 3272
2024
Q3 		$150K Sell
104,081
-9,358
-8% -$15.3K ﹤0.01% 3370
2024
Q2 		$218K Sell
113,439
-1,547
-1% -$4.36K ﹤0.01% 3180
2024
Q1 		$511K Buy
114,986
+2,878
+3% +$9.35K ﹤0.01% 2662
2023
Q4 		$349K Sell
112,108
-476
-0.4% -$1.79K ﹤0.01% 2878
2023
Q3 		$678K Sell
112,584
-983
-0.9% -$6.9K ﹤0.01% 2423
2023
Q2 		$951K Sell
113,567
-4,261
-4% -$44.3K ﹤0.01% 2319
2023
Q1 		$1.49M Sell
117,828
-7,953
-6% -$92K ﹤0.01% 1963
2022
Q4 		$1.15M Buy
125,781
+285
+0.2% +$3.08K ﹤0.01% 2057
2022
Q3 		$1.48M Buy
125,496
+10,256
+9% +$130K ﹤0.01% 1940
2022
Q2 		$1.48M Buy
115,240
+25,563
+29% +$343K ﹤0.01% 1933
2022
Q1 		$1.51M Buy
89,677
+5,701
+7% +$94.1K ﹤0.01% 1950
2021
Q4 		$2.03M Sell
83,976
-840
-1% -$21.6K ﹤0.01% 1876
2021
Q3 		$2.2M Buy
84,816
+39,694
+88% +$873K ﹤0.01% 1859
2021
Q2 		$758K Buy
+45,122
New +$617K ﹤0.01% 2370

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RhumbLine Advisers's SKIN Position: Q2 2026 in Review

RhumbLine Advisers reduced its SkinHealth Systems (SKIN) stake by 80% in Q2 2026, selling an estimated $78K and leaving 25,079 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

RhumbLine Advisers first reported a position in SKIN in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.2M in Q3 2021. 97 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • RhumbLine Advisers held 25,079 shares of SkinHealth Systems worth $17.4K as of Q2 2026.
  • RhumbLine Advisers sold 102,048 SkinHealth Systems shares in Q2 2026, an estimated $78K.
  • SkinHealth Systems made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3835 holding.
  • RhumbLine Advisers first reported a position in SkinHealth Systems in Q2 2021 and has held it in 21 quarters since.
  • RhumbLine Advisers's SkinHealth Systems position peaked at $2.2M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.